GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » PS Ratio

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) PS Ratio : 3.48 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Shijiazhuang Yiling Pharmaceutical Co's share price is ¥18.53. Shijiazhuang Yiling Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥5.33. Hence, Shijiazhuang Yiling Pharmaceutical Co's PS Ratio for today is 3.48.

Warning Sign:

Shijiazhuang Yiling Pharmaceutical Co Ltd stock PS Ratio (=3.64) is close to 1-year high of 3.8

The historical rank and industry rank for Shijiazhuang Yiling Pharmaceutical Co's PS Ratio or its related term are showing as below:

SZSE:002603' s PS Ratio Range Over the Past 10 Years
Min: 2.4   Med: 4.36   Max: 9.31
Current: 3.45

During the past 13 years, Shijiazhuang Yiling Pharmaceutical Co's highest PS Ratio was 9.31. The lowest was 2.40. And the median was 4.36.

SZSE:002603's PS Ratio is ranked worse than
68.07% of 999 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs SZSE:002603: 3.45

Shijiazhuang Yiling Pharmaceutical Co's Revenue per Sharefor the three months ended in Mar. 2024 was ¥1.51. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥5.33.

Warning Sign:

Shijiazhuang Yiling Pharmaceutical Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Shijiazhuang Yiling Pharmaceutical Co was -35.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 19.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 17.20% per year.

During the past 13 years, Shijiazhuang Yiling Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 29.40% per year. The lowest was -7.40% per year. And the median was 13.00% per year.

Back to Basics: PS Ratio


Shijiazhuang Yiling Pharmaceutical Co PS Ratio Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co PS Ratio Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.54 3.46 3.24 3.99 3.74

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.54 3.12 2.98 3.74 3.78

Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shijiazhuang Yiling Pharmaceutical Co's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shijiazhuang Yiling Pharmaceutical Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's PS Ratio falls into.



Shijiazhuang Yiling Pharmaceutical Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Shijiazhuang Yiling Pharmaceutical Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=18.53/5.331
=3.48

Shijiazhuang Yiling Pharmaceutical Co's Share Price of today is ¥18.53.
Shijiazhuang Yiling Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5.33.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Shijiazhuang Yiling Pharmaceutical Co  (SZSE:002603) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Shijiazhuang Yiling Pharmaceutical Co PS Ratio Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Executives
Zhang Qiu Lian Directors, executives
Han Yue Zhi Executives
Zhao Shao Hua Executives
Wang Wei Executives
Gao Xue Dong Supervisors
Wu Yi Ling Director
Gao Xiu Qiang Executives
Wu Xiang Jun Directors, executives
Guo Shuang Geng Director
Wang Hua Securities Affairs Representative
Dai Feng Xiang Directors, executives
Liu Gen Wu Supervisors
Wang Wei Ping Directors, executives
Xu Wei Dong Director
Wu Rui Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines